Vanda Pharmaceuticals
3 clinical trials · 3 recruiting · INDUSTRY
Trials by Vanda Pharmaceuticals
RECRUITINGPhase 3NCT06830044
Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder
The purpose of this study is to determine the efficacy and safety of milsaperidone compared to placebo as adjunctive therapy in patients with Major Depressive Disorder
Sponsor: Vanda PharmaceuticalsEnrolling: 50020 locations
Major Depressive Disorder (MDD)
RECRUITINGPhase 4NCT05648591
Safety and Tolerability of Open-Labeled Iloperidone in Adolescents
To evaluate the safety and tolerability of iloperidone in adolescent patients with schizophrenia or bipolar I disorder for up to 52 weeks of treatment.
Sponsor: Vanda PharmaceuticalsEnrolling: 1009 locations
SchizophreniaBipolar I Disorder
RECRUITINGPhase 2NCT07179055
An Eight-Week Study to Evaluate the Safety and Efficacy of VSJ-110 Compared to Placebo in the Treatment of Dry Eye
The purpose of this study is to determine the safety and efficacy of VSJ-110 compared to placebo in the treatment of dry eye.
Sponsor: Vanda PharmaceuticalsEnrolling: 1605 locations
Dry Eye